Financial Results : ProMedEx earnings leaps 51% to SAR 41.7M in 2025; H2 at SAR 19.6M

ProMedEx earnings leaps 51% to SAR 41.7M in 2025; H2 at SAR 19.6M

31/03/2026 Argaam Exclusive

View other reports

Professional Medical Expertise Co. (ProMedEx) posted a net profit leap of 51% to SAR 41.7 million in 2025 from SAR 27.6 million in 2024.



Financials (M)

Item 2024 2025 Change‬
Revenues 313.17 418.78 33.7 %
Gross Income 138.80 184.99 33.3 %
Operating Income 39.72 59.59 50.1 %
Net Income 27.65 41.71 50.8 %
Average Shares 3.50 3.50 -
Earnings Per Share before unusual items (Riyals) 7.90 11.92 50.8 %
EPS (Riyal) 7.90 11.92 50.8 %

Revenues increased by 34% year-on-year (YoY) to SAR 418.77 million, driven by the company’s business expansion through onboarding new clients and increasing sales from new agencies.

 

In addition, profit margins improved as a result of higher sales and enhanced salesforce, leading to better operational efficiency.

 

The second-half earnings rose 26% to SAR 19.60 million from SAR 15.53 million in H2 2024.

 

ProMedEx, however, reported a profit decline of 11.3% from SAR 22.10 million in H1 2025.



Current Half Annual Comparison (M)

Compared With The
Item H2 2024 H2 2025 Change‬
Revenues 165.78 228.74 38.0 %
Gross Income 76.20 99.94 31.1 %
Operating Income 22.38 32.48 45.2 %
Net Income 15.54 19.61 26.2 %
Average Shares 3.50 3.50 -
Earnings Per Share before unusual items (Riyal) 4.44 5.60 26.2 %
EPS (Riyal) 4.44 5.60 26.2 %

Total shareholders’ equity, no minority interest, reached SAR 150.20 million as of Dec. 31, 2025, up from SAR 113.19 million a year earlier.

View More Financial Results

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.